Cardiomyopathy Trial, Recruiting (NCT06060548)

Cardiomyopathy Trial, Recruiting NCT06060548 Sponsor: Kansas City Heart Rhythm Research Foundation Condition: Cardiomyopathy

Printed from Voxsanity (voxsanity.com.au) — NCT06060548 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Cardiomyopathy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are older than 18 years of age
People who have a specific small heart monitor implanted under the skin called a Medtronic LINQ II ILR
People who are willing and able to sign a written consent form

Who may not be able to join:

People who have had a heart attack in the past
People who have been found to have significant blockages (50% or more) in the arteries supplying the heart, as shown by a specialised X-ray procedure or a CT scan of the heart
People who have had a cardiac arrest (when the heart suddenly stops beating) in the past
People who already have an implanted defibrillator device (a device that delivers a shock to correct dangerous heart rhythms)
People who are currently pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Dhanunjaya Lakkireddy, MD, Kansas City Heart Rhythm Institute

Phone: 816-651-1969

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06060548

Sponsor: Kansas City Heart Rhythm Research Foundation

Phase: Not Applicable

Status: Recruiting

Condition: Cardiomyopathy

Trial contact: 816-651-1969

More information: https://clinicaltrials.gov/study/NCT06060548

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are older than 18 years of age
People who have a specific small heart monitor implanted under the skin called a Medtronic LINQ II ILR
People who are willing and able to sign a written consent form

Who may not be able to join:

People who have had a heart attack in the past
People who have been found to have significant blockages (50% or more) in the arteries supplying the heart, as shown by a specialised X-ray procedure or a CT scan of the heart
People who have had a cardiac arrest (when the heart suddenly stops beating) in the past
People who already have an implanted defibrillator device (a device that delivers a shock to correct dangerous heart rhythms)
People who are currently pregnant

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Kansas City Heart Rhythm Research Foundation

Registry

ClinicalTrials.gov

Start date

20 April 2022

Est. completion

1 September 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Identification of unrecognized myocarditis; Evaluation of efficacy of immunosuppressive therapy - PVC burden reduce; Evaluation of efficacy of immunosuppressive therapy - LVEF improvement; Associated atrial and ventricular arrhythmias

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov